Jianfeng Han
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Viral Infections and Immunology Research 20
-
- RNA Interference and Gene Delivery 6
- Co-authors
- Jianhua Yu (11 shared papers)Cheng‐Feng Qin (24 shared papers)Zhirong Zhang (7 shared papers)Xun Sun (8 shared papers)Xiaoming He (5 shared papers)Tao Gong (4 shared papers)Qi-En Wang (2 shared papers)Yong‐Qiang Deng (16 shared papers)
- Journals
- PLoS ONE (5 papers)Journal of Virology (3 papers)Scientific Reports (3 papers)Optics Express (3 papers)Virology Journal (3 papers)
- Partner nations
- ChinaUnited StatesBelarus
In The Last Decade
Jianfeng Han
94 papers receiving 3.4k citations
Jianfeng Han's Hit Papers
Peers
Comparison fields: 5 of 148
- Immunology 690
- Biomaterials 454
- Oncology 816
- Infectious Diseases 493
- Cardiology and Cardiovascular Medicine 499
Countries citing papers authored by Jianfeng Han
This map shows the geographic impact of Jianfeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfeng Han more than expected).
Fields of papers citing papers by Jianfeng Han
This network shows the impact of papers produced by Jianfeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfeng Han. The network helps show where Jianfeng Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianfeng Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 296 | |
| 2 | 2015 | 255 | |
| 3 | 2016 | 213 | |
| 4 | TGF-β signaling and its targeting for glioma treatment. | 2015 | 166 |
| 5 | 2013 | 146 | |
| 6 | 2013 | 145 | |
| 7 | Prevalence of stroke in China, 2013–2019: A population-based study Hit paper breakdown → | 2022 | 122 |
| 8 | 2016 | 104 | |
| 9 | 2016 | 90 | |
| 10 | 2013 | 82 | |
| 11 | 2013 | 80 | |
| 12 | 1990 | 79 | |
| 13 | 2015 | 77 | |
| 14 | 2018 | 70 | |
| 15 | 2014 | 69 | |
| 16 | 2011 | 61 | |
| 17 | p53 status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expressing c-Myc. | 1997 | 49 |
| 18 | 2013 | 48 | |
| 19 | 2013 | 48 | |
| 20 | 2015 | 45 |
About Jianfeng Han
Jianfeng Han is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Epidemiology, Infectious Diseases and Immunology, having authored 102 papers that have together received 3.5k indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (20 papers), Virus-based gene therapy research (10 papers), Viral gastroenteritis research and epidemiology (7 papers), Immune Cell Function and Interaction (7 papers), Animal Disease Management and Epidemiology (7 papers), RNA Interference and Gene Delivery (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (690 citations), Biomaterials (454 citations), Oncology (816 citations), Infectious Diseases (493 citations) and Cardiology and Cardiovascular Medicine (499 citations). Jianfeng Han has collaborated with scholars based in China, United States and Belarus. Frequent co-authors include Jianhua Yu, Cheng‐Feng Qin, Zhirong Zhang, Xun Sun, Xiaoming He, Tao Gong, Qi-En Wang, Yong‐Qiang Deng, E-De Qin and Tao Jiang. Their work appears in journals such as PLoS ONE, Journal of Virology, Scientific Reports, Optics Express and Virology Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.